IRIS
MARAFINI, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.787
EU - Europa 1.028
AS - Asia 851
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 8
AF - Africa 3
OC - Oceania 1
Totale 14.686
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.775
SG - Singapore 419
CN - Cina 231
IT - Italia 205
IE - Irlanda 194
DE - Germania 152
UA - Ucraina 118
HK - Hong Kong 106
RU - Federazione Russa 99
GB - Regno Unito 76
KR - Corea 50
FI - Finlandia 46
SE - Svezia 37
FR - Francia 33
PL - Polonia 23
BE - Belgio 13
ID - Indonesia 12
CA - Canada 10
JP - Giappone 8
NL - Olanda 8
IN - India 7
LT - Lituania 5
A1 - Anonimo 4
BR - Brasile 4
CH - Svizzera 4
PH - Filippine 4
AT - Austria 3
ES - Italia 3
EU - Europa 3
IL - Israele 3
BD - Bangladesh 2
BG - Bulgaria 2
CL - Cile 2
EG - Egitto 2
HU - Ungheria 2
NO - Norvegia 2
SA - Arabia Saudita 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
IR - Iran 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MA - Marocco 1
RO - Romania 1
TW - Taiwan 1
Totale 14.686
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.340
Wilmington 3.186
Houston 3.020
Fairfield 565
Singapore 380
Chandler 310
Ann Arbor 308
Ashburn 277
Seattle 244
Cambridge 194
Dublin 163
Medford 131
Rome 122
Hong Kong 105
Santa Clara 99
Jacksonville 98
Dearborn 93
Beijing 85
Lawrence 60
Council Bluffs 35
New York 35
San Diego 34
Zhengzhou 34
Menlo Park 27
Kraków 21
London 19
Helsinki 17
Milan 15
Seoul 15
Moscow 14
Brussels 13
Shanghai 13
Colorado Springs 12
Jakarta 12
Norwalk 11
Chicago 10
Redwood City 10
Kunming 8
Los Angeles 8
Del Norte 7
Mountain View 7
Hefei 6
Naples 6
North Hollywood 6
Nuremberg 6
Toronto 6
Boardman 5
Orlando 5
Saint Louis 5
San Francisco 5
Verona 5
Atlanta 4
Hangzhou 4
Kilburn 4
Manila 4
Monte Porzio Catone 4
Palo Alto 4
The Dalles 4
Chennai 3
Detroit 3
Falls Church 3
Frankfurt am Main 3
Fuzhou 3
Lusciano 3
Nürnberg 3
Tokyo 3
Wuhan 3
Adana 2
Amsterdam 2
Bari 2
Bologna 2
Cairo 2
Casina 2
Changsha 2
Chengdu 2
Durham 2
Guangzhou 2
Hebei 2
Holon 2
Hounslow 2
Indiana 2
Lappeenranta 2
Lausanne 2
Magenta 2
Miami 2
Munich 2
Nanjing 2
Pescara 2
Phoenix 2
Porto Alegre 2
Quzhou 2
Redmond 2
San Jose 2
Shenyang 2
University Park 2
Warsaw 2
Acton 1
Baku 1
Barsinghausen 1
Berlin 1
Totale 13.329
Salva come PNG Salva come JPEG
Nome #
Interleukin-34 sustains inflammatory pathways in the gut 461
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 454
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 449
null 442
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 434
The dual role of Smad7 in the control of cancer growth and metastasis 432
High Smad7 sustains inflammatory cytokine response in refractory coeliac disease 431
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 421
Pyoderma gangrenosum in refractory celiac disease: a case report 417
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 417
Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut 411
Celiac disease-related inflammation is marked by reduction of Nkp44/Nkp46-double positive natural killer cells 407
An overview of the role of innate lymphoid cells in gut infections and inflammation 405
Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease 402
Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients 401
Interleukin-34 induces Cc-chemokine ligand 20 in gut epithelial cells 399
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide 390
Defective expression of scavenger receptors in celiac disease mucosa 388
Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut 387
The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in Man 375
Antisense approach to inflammatory bowel disease: Prospects and challenges 371
TGF-Beta signaling manipulation as potential therapy for IBD 370
The TGF-β/Smad System in IBD Pathogenesis 363
Targeting integrins and adhesion molecules to combat inflammatory bowel disease 356
Proteinase activated-receptors-associated signaling in the control of gastric cancer 338
Smad7 positively regulates keratinocyte proliferation in psoriasis 332
Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities 321
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 315
Interleukin-34 sustains inflammatory pathways in the gut 314
Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities 313
Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad 312
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 309
Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice 295
Inflammatory cytokines: from discoveries to therapies in IBD 174
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 166
Extent of mucosal inflammation in ulcerative colitis influences the clinical remission induced by vedolizumab 163
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 163
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 138
Novel therapeutic options for people with ulcerative colitis: an update on recent developments with Janus Kinase (JAK) inhibitors 95
High frequency of undiagnosed psychiatric disorders in inflammatory bowel diseases 92
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 91
NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals 90
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 87
null 77
Association between celiac disease and cancer 75
The Fragile X Mental Retardation Protein Regulates RIPK1 and Colorectal Cancer Resistance to Necroptosis 73
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 53
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer 49
Effect of Vedolizumab on anemia of chronic disease in patients with inflammatory bowel diseases 45
An essential role of adenosine deaminase acting on RNA 1 in coeliac disease mucosa 43
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 42
Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders 39
Niclosamide enema for active distal ulcerative colitis: a phase I, open-label study 37
Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease 33
Low frequency of COVID-19 in inflammatory bowel diseases 33
Low Frequency of Acute Pancreatitis in Hospitalized COVID-19 Patients 31
Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment 30
Metalloproteinases in inflammatory bowel diseases 30
Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab 28
Interleukin-34 promotes tumorigenic signals for colon cancer cells 28
Long-term outcomes and predictive factors of hospitalized patients with severe ulcerative colitis treated with intravenous corticosteroids 25
Respiratory Tract Infections in Inflammatory Bowel Disease Patients Taking Vedolizumab: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 24
Involvement of smad7 in inflammatory diseases of the gut and colon cancer 24
Smoking and colorectal cancer in inflammatory bowel disease: Quantity matters? 23
Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features 22
Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literature 21
Precision Medicine in Inflammatory Bowel Diseases 21
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms 21
Frequency and Predictors of Dysplasia in Pseudopolyp-like Colorectal Lesions in Patients with Long-Standing Inflammatory Bowel Disease 19
Natural History of Ulcerative Colitis with Coexistent Colonic Diverticulosis. 18
Endoscopic Predictors of Neoplastic Lesions in Inflammatory Bowel Diseases Patients Undergoing Chromoendoscopy 17
No effect of a liquid diet in the management of patients with stricturing Crohn’s disease 17
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? 17
Gut microbiota analysis in inflammatory bowel disease: Novel findings from old data 16
Reversibility of Frail Phenotype in Patients with Inflammatory Bowel Diseases 15
null 14
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer 14
Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice 13
Preventable predictive factors of post-colonoscopy colorectal cancer in inflammatory bowel disease 10
Quality of clinical guidelines: It matters as it impacts patient care 8
Treatment options for refractory ulcerative colitis: Small molecules, big effects 8
Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long term 7
Aryl Hydrocarbon Receptor Signalling in the Control of Gut Inflammation 7
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease 7
Inflammatory bowel disease: new therapies from antisense oligonucleotides 6
Vedolizumab and new‐onset spondyloarthritis: Debunking the myth 6
Oligonucleotide-Based Therapies for Inflammatory Bowel Disease 6
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 4
null 3
null 3
Protective Effects of Aryl Hydrocarbon Receptor Signaling in Celiac Disease Mucosa and in Poly I:C-Induced Small Intestinal Atrophy Mouse Model 2
Totale 15.055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.564
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.564
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.809 0 0 0 0 0 0 343 327 351 324 223 241
2020/20212.556 202 268 347 303 269 287 296 246 58 160 79 41
2021/2022657 40 26 24 30 15 48 26 19 140 68 65 156
2022/2023760 70 87 18 98 69 169 69 37 56 32 37 18
2023/2024312 36 5 15 8 24 52 23 61 5 5 19 59
2024/20251.286 39 423 357 135 59 269 4 0 0 0 0 0
Totale 15.055